The board may not take disciplinary action against a licensee based solely on the licensee prescribing or dispensing ivermectin for the off-label treatment or prevention of severe acute respiratory syndrome coronavirus 2 identified as SARS-CoV-2, or any mutation or viral fragments of SARS-CoV-2. This section does not limit the board from taking a disciplinary action on another basis, such as unlicensed practice, inappropriate documentation, or substandard care, or any basis that would in the board's determination harm the patient.
Limitations on disciplinary actions
N.D.C.C. § 43-17-31.2 — under Physicians, Resident Physicians, and Physician Assistants.
N.D.C.C. § 43-17-31.2